CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
68.92
-0.28 (-0.40%)
At close: Apr 15, 2025, 4:00 PM
68.97
+0.05 (0.07%)
After-hours: Apr 15, 2025, 7:04 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for CVS Health stock have an average target of 72, with a low estimate of 58 and a high estimate of 82. The average target predicts an increase of 4.47% from the current stock price of 68.92.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 7 | 6 | 5 | 5 | 5 |
Buy | 7 | 7 | 7 | 8 | 8 | 8 |
Hold | 4 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 17 | 16 | 16 | 16 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Baird | Baird | Hold Maintains $51 → $71 | Hold | Maintains | $51 → $71 | +3.02% | Apr 15, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $76 → $82 | Strong Buy | Maintains | $76 → $82 | +18.98% | Apr 11, 2025 |
Mizuho | Mizuho | Buy Maintains $70 → $76 | Buy | Maintains | $70 → $76 | +10.27% | Apr 9, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $72 → $74 | Buy | Maintains | $72 → $74 | +7.37% | Mar 21, 2025 |
JP Morgan | JP Morgan | Buy Maintains $80 → $81 | Buy | Maintains | $80 → $81 | +17.53% | Feb 18, 2025 |
Financial Forecast
Revenue This Year
393.08B
from 370.66B
Increased by 6.05%
Revenue Next Year
412.28B
from 393.08B
Increased by 4.89%
EPS This Year
5.96
from 3.66
Increased by 62.91%
EPS Next Year
6.89
from 5.96
Increased by 15.56%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 419.2B | 446.1B | 482.4B | ||
Avg | 393.1B | 412.3B | 434.2B | ||
Low | 374.6B | 383.0B | 399.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.1% | 13.5% | 17.0% | ||
Avg | 6.0% | 4.9% | 5.3% | ||
Low | 1.1% | -2.6% | -3.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 6.83 | 7.97 | 9.45 | ||
Avg | 5.96 | 6.89 | 7.89 | ||
Low | 5.52 | 6.14 | 6.50 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 86.5% | 33.7% | 37.2% | ||
Avg | 62.9% | 15.6% | 14.5% | ||
Low | 50.7% | 2.9% | -5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.